Medasense Biometrics's guest appearances

Medasense Biometrics

Healthcare NOW Radio Podcast Network - Discussions on healthcare including technology, innovation, policy, data security, telehealth and more. Visit HealthcareNOWRadio.com

HealthTech Israel Podcast

OwlTail

Galit Zuckerman-Stark

S1E7: Join Galit Zuckerman-Stark, CEO and Founder of Medasense Biometrics, and host Jared Johnson as they discuss the FDA's new mandate for better safety warnings on opioid medications, the issue of post-op opioid dependence, and a new solution that provides clinicians with real-time insight into a patient's physiological pain response during surgery.To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio.”Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

S1E7: Join Galit Zuckerman-Stark, CEO and Founder of Medasense Biometrics, and host Jared Johnson as they discuss the FDA's new mandate for better safety warnings on opioid medications, the issue of post-op opioid dependence, and a new solution that provides clinicians with real-time insight into a patient's physiological pain response during surgery. To stream our Station live 24/7 visit <a href="http://www.HealthcareNOWRadio.com" rel="nofollow" target="_blank">www.HealthcareNOWRadio.com</a> or ask your Smart Device to “….Play Healthcare NOW Radio.” Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at <a href="http://www.healthcarenowradio.com/listen" rel="nofollow" target="_blank">www.healthcarenowradio.com/listen</a>

Trending NOW: Galit Zuckerman-Stark, CEO and founder, Medasense Biometrics

Galit Zuckerman Stark, CEO and cofounder of Medasense. Medasense is NOL technology, enables clinician to personalize pain management, optimize treatment and avoid overmedication. All this in it with a noninvasive sensor platform and AI technology. 01:14 What brought you to the medical field and to becoming the CEO of a breakthrough product in what is actually a very difficult market to operate in?03:18 How did you get to pain as a field of interest?05:05 Why is there a need for an objective measurement of pain?09:05 Can you go back to 10-11 years ago and share what you were thinking your product process was going to be? And then go to, where you are now and what your product actually is?13:40 What do you think are the main things that have changed in the “Pain industry” and allowed you to sell products and raise significant amounts of capital from investors?16:46 Can you explain a little bit about how Medasense’s technology works? 20:03 How is Medasense’s pain score personalized?20:59 Are you only addressing the pain component of surgery or are you helping the anesthesiologist manage the types of medications administered during surgery?22:54 How and why did you make the decision to work with a large multinational company such as Medtronic for distribution?26:08 it's quite unusual for an Israeli company to start with Europe. Why did you decide to begin your sales in Europe? 28:50 How do you make sure you don’t lose touch with the market when you sell through distributors? 34:10 Who helped you during the transition from a product company to a commercialization36:59 What's next for Medasense?41:05 How does your product work with patients who can communicate? How can you reconcile the gap between your measurement and what the patient is saying? 43:20 Do you think you have different challenges because you're a female CEO in this space? And if so, you know, do you have any tips for other female CEOs?

Galit Zuckerman Stark, CEO and cofounder of Medasense. Medasense is NOL technology, enables clinician to personalize pain management, optimize treatment and avoid overmedication. All this in it with a noninvasive sensor platform and AI technology. 01:14 What brought you to the medical field and to becoming the CEO of a breakthrough product in what is actually a very difficult market to operate in?03:18 How did you get to pain as a field of interest?05:05 Why is there a need for an objective measurement of pain?09:05 Can you go back to 10-11 years ago and share what you were thinking your product process was going to be? And then go to, where you are now and what your product actually is?13:40 What do you think are the main things that have changed in the “Pain industry” and allowed you to sell products and raise significant amounts of capital from investors?16:46 Can you explain a little bit about how Medasense’s technology works? 20:03 How is Medasense’s pain score personalized?20:59 Are you only addressing the pain component of surgery or are you helping the anesthesiologist manage the types of medications administered during surgery?22:54 How and why did you make the decision to work with a large multinational company such as Medtronic for distribution?26:08 it's quite unusual for an Israeli company to start with Europe. Why did you decide to begin your sales in Europe? 28:50 How do you make sure you don’t lose touch with the market when you sell through distributors? 34:10 Who helped you during the transition from a product company to a commercialization36:59 What's next for Medasense?41:05 How does your product work with patients who can communicate? How can you reconcile the gap between your measurement and what the patient is saying? 43:20 Do you think you have different challenges because you're a female CEO in this space? And if so, you know, do you have any tips for other female CEOs?